Y. Yoto et al., RETROSPECTIVE STUDY ON THE INFLUENCE OF HUMAN PARVOVIRUS B19 INFECTION AMONG CHILDREN WITH MALIGNANT DISEASES, Acta haematologica, 90(1), 1993, pp. 8-12
Human parvovirus B19 (B19) is a known cause of erythema infectiosum (f
ifth disease) and aplastic crisis in patients with hemolytic anemias.
When patients with malignant diseases are infected by B19 during chemo
therapy, erythroid suppression of bone marrow sometimes occurs. We per
formed a retrospective investigation of B19 infection among 95 childre
n with malignant diseases in our hospital during the past 14 years. By
the method of dot blot hybridization, 9 of 95 patients were found to
be positive for B19 DNA during chemotherapy. All 9 patients had reticu
locytopenia at the time B19 DNA was detected in their serum samples. N
eutropenia and thrombocytopenia were not found. Seven of them had only
transient reticulocytopenia. Serum samples from 2 other patients were
positive for B19 DNA for a longer time. They suffered from persistent
anemia for about 2 and 13 month, respectively. The years when B19 DNA
was detected from the 9 patients corresponded to the prevalence of er
ythema infectiosum in Japan.